American Chemical Society
|Agreement labeling||ACS online products subscription with offset Open Access publishing (Consortia Offset Benefit Program)|
|Has the agreement been disclosed and published?||To be published|
|Agreement period||01/01/2020 – 31/12/2023|
|Consortia / Institution||CRUI-CARE|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
|Comments on cost development||The increase of the annual cost decrease during the term of the agreement|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|OA publications included in the overall subscription fee|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Eventual unused Tokens can be used for 24 months after the year of entitlement only for the conversion of articles published in the entitled year or earlier. Eventual additional Tokens can be purchased at a reduced rate.|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY mandatory|
||All article types included, with the exception of ebook|
What is the approximate share of access related costs of the overall agreement?
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|OVERALL ASSESSMENT AND COMMENTS||We consider this agreement sustainable with regards to costs and workflow|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|